4,0
16. Juli 2010
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Madison, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
happy to be part of an environment that researches the best drugs in the marketplace and seeks to commercialized them better than anyone else
Kontras
I believe they need to invest more in R&D and less on acquiring other companies for their pipeline; the future of these pharma companies is internal development